BioCorRx (BICX) Capital Expenditures (2013 - 2021)

BioCorRx (BICX) posted Capital Expenditures of $2017.0 for Q1 2021, up 131.52% sequentially from -$6400.0 in Q4 2020.

BioCorRx (BICX) Capital Expenditures (2013 - 2021) Analysis & Trends

BioCorRx has reported Capital Expenditures for 7 years, with the latest figure at $2017.0 in Q1 2021.

Quarterly Capital Expenditures changed N/A year-over-year to $2017.0 in Q1 2021, while the trailing twelve-month figure through Dec 2021 was $2017.0 (changed N/A YoY) and the FY2021 annual result came in at $2017.0, changed N/A from the prior year.
Capital Expenditures rose to $2017.0 in Q1 2021 per BICX's latest filing, from -$6400.0 in the prior quarter.
Over five years, Capital Expenditures peaked at $105540.0 in Q2 2019 and troughed at -$135251.0 in Q3 2019.
A 4-year average of -$20098.4 and a median of -$6400.0 in 2020 frame the typical range for Capital Expenditures.
The sharpest annual moves came in 2019 and 2020: Capital Expenditures plunged 5486.18% in 2019, then soared 104.73% in 2020.
Over 4 years, Capital Expenditures stood at -$984.0 in 2018, then slumped by 5486.18% to -$54968.0 in 2019, then jumped by 88.36% to -$6400.0 in 2020, then jumped by 131.52% to $2017.0 in 2021.
According to Business Quant data, Capital Expenditures over the past three periods registered $2017.0, -$6400.0, and $6400.0 for Q1 2021, Q4 2020, and Q3 2020 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Capital Expenditures (Qtr)
1	HCA Healthcare	88.19 Bn	90.61 Bn	15.19 Bn	1.23 Bn
2	Tenet Healthcare	21.59 Bn	21.56 Bn	4.45 Bn	168.00 Mn
3	Encompass Health	12.19 Bn	12.86 Bn	1.34 Bn	220.30 Mn
4	Davita	11.52 Bn	12.39 Bn	1.16 Bn	169.82 Mn
5	Ensign	10.59 Bn	10.27 Bn	306.24 Mn	52.83 Mn
6	Universal Health Services	8.79 Bn	8.72 Bn	3.29 Bn	227.63 Mn
7	Pacs	7.04 Bn	6.88 Bn	338.46 Mn	104.28 Mn
8	Chemed	6.96 Bn	6.92 Bn	221.47 Mn	15.52 Mn
9	Concentra Group Holdings Parent	4.52 Bn	4.38 Bn	192.10 Mn	15.67 Mn
10	BioCorRx	1.49 Mn	1.47 Mn	-	-

Download Data